← FDA Drug Approvals (Drugs@FDA)
FLUDEOXYGLUCOSE F18
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UNIV UTAH CYCLOTRON · Approved 2015-06-23
Drug application
- FDA Application #
ANDA204498- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUDEOXYGLUCOSE F18
- Generic name
- FLUDEOXYGLUCOSE F 18
- Active ingredients
- FLUDEOXYGLUCOSE F-18
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- UNIV UTAH CYCLOTRON
- Manufacturer
- The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute
- First approval
- 2015-06-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown